Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.

J Transl Med · 2011 · PMC3032678 · PMID 21255386

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Discussion In this multicentre cohort study of prospectively assessed HIV-1 drug resistance in patients the addition of rPRT to GRT as compared to GRT alone showed a trend towards improved success rates for treatment with increasing levels of antiretroviral pre-treatment.

also in 53,322 other papers

highly significantno p-value reported

For the pre-specified subgroup of patients with >2 previous drug failures this association was highly significant in multivariate analysis when adjusting for age, gender, IDU, baseline HIV-1 RNA, CD4 nadir, number of previous regimens, class of cART, and missed doses of cART (OR 1.68, 95% CI 1.31-2.15) (Table 4 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.